CIK 0001880438
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
AN2 Therapeutics, Inc.
Sign in to watch- Ticker
- ANTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 820606654
- Phone
- +1 650-331-9090
- Business address
- 1300 EL CAMINO REAL, SUITE 100, MENLO PARK, CA, 94025
- Open-market buys, last 90 days
- $11,602
- in 1 filing
- Open-market sales, last 90 days
- $117,428
- in 4 filings, $104K under 10b5-1 plans
Net −$105,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-10-02 | Aziz Kabeer Director | Sale | −4,770 | $16.07 | $77K | 2,081,573 |
| 2023-10-02 | Aziz Kabeer Director | Sale | −902 | $16.07 | $14K | 393,737 |
| 2023-10-02 | Adjuvant Global Health Technology Fund, L.P. 10% owner | Sale | −4,770 | $16.07 | $77K | 2,081,573 |
| 2023-10-02 | Adjuvant Global Health Technology Fund, L.P. 10% owner | Sale | −902 | $16.07 | $14K | 393,737 |
| 2023-09-29 | Aziz Kabeer Director | Sale | −83,337 | $16.28 | $1.4M | 2,086,343 |
| 2023-09-29 | Aziz Kabeer Director | Sale | −15,764 | $16.28 | $257K | 394,639 |
| 2023-09-29 | Adjuvant Global Health Technology Fund, L.P. 10% owner | Sale | −83,337 | $16.28 | $1.4M | 2,086,343 |
| 2023-09-29 | Adjuvant Global Health Technology Fund, L.P. 10% owner | Sale | −15,764 | $16.28 | $257K | 394,639 |
| 2023-09-28 | Adjuvant Global Health Technology Fund, L.P. 10% owner | Sale | −7,160 | $16.11 | $115K | 2,169,680 |
| 2023-09-28 | Adjuvant Global Health Technology Fund, L.P. 10% owner | Sale | −1,356 | $16.11 | $22K | 410,403 |
| 2023-09-28 | Aziz Kabeer Director | Sale | −7,160 | $16.11 | $115K | 2,169,680 |
| 2023-09-28 | Aziz Kabeer Director | Sale | −1,356 | $16.11 | $22K | 410,403 |
| 2023-09-27 | Adjuvant Global Health Technology Fund, L.P. 10% owner | Sale | −707 | $16.07 | $11K | 2,176,840 |
| 2023-09-27 | Adjuvant Global Health Technology Fund, L.P. 10% owner | Sale | −134 | $16.07 | $2K | 411,759 |
| 2023-09-27 | Aziz Kabeer Director | Sale | −707 | $16.07 | $11K | 2,176,840 |
| 2023-09-27 | Aziz Kabeer Director | Sale | −134 | $16.07 | $2K | 411,759 |
| 2023-09-13 | Aziz Kabeer Director | Sale | −336 | $16.00 | $5K | 2,177,547 |
| 2023-09-13 | Aziz Kabeer Director | Sale | −64 | $16.00 | $1K | 411,893 |
| 2023-09-13 | Adjuvant Global Health Technology Fund, L.P. 10% owner | Sale | −336 | $16.00 | $5K | 2,177,547 |
| 2023-09-13 | Adjuvant Global Health Technology Fund, L.P. 10% owner | Sale | −64 | $16.00 | $1K | 411,893 |
Page 13 of 20 · 385 trades